Skip to main content
PMC home page
Cancer Immunology, Immunotherapy : CII logoLink to Cancer Immunology, Immunotherapy : CII
. 1983 Oct;16(1):23–29. doi: 10.1007/BF00199901

Humoral and cellular immune reactions against tumor cells in patients with urinary bladder carcinoma

Correlation between direct and antibody-dependent cell-mediated cytotoxicity

Yngve Hansson 1,✉, Staffan Paulie 1, Åke Larsson 1, Marie-Louise Lundblad 1, Peter Perlmann 1, Ingemar Näslund 2
PMCID: PMC11039116  PMID: 6556949

Abstract

Serum IgG fractions from a large and homogenous group of patients with transitional cell carcinoma of the urinary bladder (TCC) were tested for their capacity to induce antibody-dependent cellular cytotoxicity (ADCC) with lymphocytes from healthy donors against a TCC-derived target cell and one derived from adenocarcinoma of the colon. Both targets have previously been shown to be of comparable susceptibility to cell-mediated lysis in vitro. Some of the IgG preparations showed strong and dose-dependent ADCC against either one or both targets, while others gave weak reactions or none at all. Similar results were obtained with IgG from a matched group of patients with prostatic carcinoma who were used as clinical controls (CC). In parallel experiments, lymphocytes taken from the two donor groups at the same time as the serum samples were tested for their direct cytotoxicity (CMC) against the two targets. CMC gave similar results to ADCC. The differences in cytotoxicity displayed by either IgG or lymphocytes from individual donors were analysed statistically, using nonparametric statistics. To avoid introducing bias due to arbitrary data selection, the entire set of results, comprising both high and low reactors, was included in the statistical assessment. ADCC of the TCC donors' IgG against the TCC target was significantly stronger than against the colon carcinoma and also significantly stronger than that of the control donors. Similarly, the TCC patients' lymphocytes displayed a significantly higher CMC against the TCC target than against the control targets. This was not seen when the lymphocytes from the patients with prostatic carcinoma were tested. When CMC and ADCC of individual donors were compared, a statistically significant correlation between these activities was seen in three of the four donor/target combinations. These results support earlier findings and suggest that a significant fraction of both the disease-related and the ‘non-selective’ CMC (NK) displayed by cancer patients lymphocytes against allogeneic tumor cells in vitro reflects antibody-dependent reactions.

Keywords: Urinary Bladder, Colon Carcinoma, Prostatic Carcinoma, Transitional Cell Carcinoma, Bladder Carcinoma

References

  • 1.Armitage P. Statistical methods in medical research. London: Blackwell; 1971. [Google Scholar]
  • 2.Bowman KO, Shenton LR. Omnibus test contours for departures from normality on b1 and b2. Biometrika. 1975;2:243. [Google Scholar]
  • 3.Bubenik J, Baresova M, Viklicky V, Jakoubkova J, Sainerova H, Donner J. Established cell line of urinary bladder carcinoma (T24) containing tumor-specific antigen. Int J Cancer. 1973;11:765. doi: 10.1002/ijc.2910110327. [DOI] [PubMed] [Google Scholar]
  • 4.Fogh J, Trempe G. New tumor lines. In: Fogh J, editor. Human tumor cells in vitro. New York: Plenum Press; 1975. p. 115. [Google Scholar]
  • 5.Gale DG, MacLennan JC. Cytotoxic antibody in acute myeloblastic leukemia during immunotherapy: Lack of specificity. Br J Cancer. 1977;35:280. doi: 10.1038/bjc.1977.40. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Hahn WV, Kagnoff MF, Hatlen LH. Immune responses in human colon cancer. II. Cytotoxic antibody detected in patients' sera. J Natl Cancer Inst. 1978;60:779. doi: 10.1093/jnci/60.4.779. [DOI] [PubMed] [Google Scholar]
  • 7.Hakala RT, Lange PH, Castro AE, Elliot AY, Fraley EE. Lymphocyte-antibody interaction in cytotoxicity against human transitional cell carcinoma. J Urol. 1975;113:663. doi: 10.1016/s0022-5347(17)59548-8. [DOI] [PubMed] [Google Scholar]
  • 8.Hammarström S, Troye M, Wahlund G, Svenberg T, Perlmann P. K-cell mediated lysis of cultured colon carcinoma and urinary bladder carcinoma cells induced by monospecific antisera against carcinoembryonic antigen (CEA) and two CEA-related normal glycoproteins. Int J Cancer. 1977;19:756. doi: 10.1002/ijc.2910190604. [DOI] [PubMed] [Google Scholar]
  • 9.Herberman RB, editor. NK cells and other natural effector cells. New York: Academic Press; 1982. [Google Scholar]
  • 10.Hersey P, Honeyman M, Edwards A, Adams E, McCarthy WH. Antigens on melanoma cells detected by leucocyte dependent antibody assays of human melanoma antisera. Int J Cancer. 1976;18:564. doi: 10.1002/ijc.2910180504. [DOI] [PubMed] [Google Scholar]
  • 11.Hjelm H, Hjelm K, Sjöquist J. Protein A from Staphylococcus aureus: Its isolation by affinity chromatography and its use as an immunosorbent for isolation of immunoglobulins. FEBS Lett. 1972;28:73. doi: 10.1016/0014-5793(72)80680-x. [DOI] [PubMed] [Google Scholar]
  • 12.Irie RF, Irie K, Morton DL. Natural antibody in human serum to a neoantigen in human cultured cells grown in fetal bovine serum. J Natl Cancer Inst. 1974;52:1051. doi: 10.1093/jnci/52.4.1051. [DOI] [PubMed] [Google Scholar]
  • 13.Jacobsen F. Cellular and humoral in vitro cytotoxicity against autologous bladder tumor cells in humans. Acta Path Microbiol Scand [C] 1981;89:235. doi: 10.1111/j.1699-0463.1981.tb02693.x. [DOI] [PubMed] [Google Scholar]
  • 14.Kerbel RS, Blakeslee D. Rapid adsorption of foetal calf serum component by mammalian cells in culture. A potential source of artefacts in studies of antisera to cell-specific antigens. Immunology. 1976;31:881. [PMC free article] [PubMed] [Google Scholar]
  • 15.Livingstone PO, Michitsch R, Shiku J, Pinsky CM, Oettgen HF. Antibody-dependent cell-mediated cytotoxicity for cultured autologous melanoma cells. Cell Immunol. 1981;64:131. doi: 10.1016/0008-8749(81)90464-0. [DOI] [PubMed] [Google Scholar]
  • 16.Matsunaga K, Mashiba H, Gojobori M, Jimi S. Antibocy-dependent cell-mediated cytotoxicity of sera from cancer patients against cultured cervical cancer cell lines. Gan. 1979;70:1. [PubMed] [Google Scholar]
  • 17.Morgan AC, Rossen RD, McCormick KJ, Stehlin JS, Jr, Giovanella BC. “Hidden” cytotoxic antibodies that react with allogeneic cultured fetal and tumor cells contained in soluble immune complexes from normal human sera. Cancer Res. 1982;42:881. [PubMed] [Google Scholar]
  • 18.O'Toole C, Perlmann P, Unsgaard B, Almg»rd LE, Johansson B, Moberger G, Edsmyr F. Cellular immunity to human bladder carcinoma. I. Correlation to clinical stage and radiotherapy. Int J Cancer. 1972;10:77. doi: 10.1002/ijc.2910100111. [DOI] [PubMed] [Google Scholar]
  • 19.O'Toole C, Perlmann P, Unsgaard B, Almg»rd LE, Johansson B, Moberger G, Edsmyr F. Cellular immunity to human urinary bladder carcinoma. II. Effect of surgery and preoperative irradiation. Int J Cancer. 1972;10:92. doi: 10.1002/ijc.2910100112. [DOI] [PubMed] [Google Scholar]
  • 20.Pape GR, Troye M, Axelsson B, Perlmann P. Simultaneous occurrence of immunoglobulin-dependent mechanisms in natural cytotoxicity of human lymphocytes. J Immunol. 1979;122:2251. [PubMed] [Google Scholar]
  • 21.Paulie S, Hansson Y, Lundblad M-L, Perlmann P. Lectins as probes for identification of tumor-associated antigens on urothelial and colonic carcinoma cell lines. Int J Cancer. 1983;31:297. doi: 10.1002/ijc.2910310308. [DOI] [PubMed] [Google Scholar]
  • 22.Perlmann P, Cerrotini CJ. Cytotoxic lymphocytes. In: Sela M, editor. The antigens, vol 5. New York: Academic Press; 1979. p. 173. [Google Scholar]
  • 23.Perlmann H, Perlmann P, Pape GR, Hallden G. Purification, fractionation and assay of antibody-dependent lymphocytic effector cells (K-cells) in human blood. Scand J Immunol. 1976;5:57. doi: 10.1111/j.1365-3083.1976.tb03856.x. [DOI] [PubMed] [Google Scholar]
  • 24.Peter HH, Kalden JR, Seeland P, Diehl V, Eckert G. Humoral and cellular immune reactions in vitro against allogeneic and autologous human melanoma cells. Clin Exp Immunol. 1975;35:280. [PMC free article] [PubMed] [Google Scholar]
  • 25.Plain MJ, Whitehead RH, Jose DG. Use of antibody-dependent cellular cytotoxicity test to detect antibodies in sera of breast cancer patients. J Natl Cancer Inst. 1981;66:619. [PubMed] [Google Scholar]
  • 26.Schneider MU, Troye M, Paulie S, Perlmann P. Plasma membrane-associated antigens in transitional cell carcinoma of the urinary bladder. I. Immunological characterization of plasma membrane-associated antigens by xenogenic antisera. Int J Cancer. 1980;26:185. doi: 10.1002/ijc.2910260210. [DOI] [PubMed] [Google Scholar]
  • 27.Schneider MU, Paulie S, Troye M, Perlmann P. Plasma membrane-associated antigens on tumor cells derived from transitional cell carcinoma of the human urinary bladder. II. Identification at the molecular level of plasma membrane-associated antigens. Int J Cancer. 1980;26:193. doi: 10.1002/ijc.2910260211. [DOI] [PubMed] [Google Scholar]
  • 28.Shoham J, Cohen M. Antibody-dependent cellular cytotoxicity to human colon-tumor cells. I. Lack of tumor specificity in a population study. Br J Cancer. 1979;40:234. doi: 10.1038/bjc.1979.171. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Troye M, Perlmann P, Larsson Å, Blomgren H, Johansson B. Cellular cytotoxicity in vitro in transitional cell carcinoma of the human urinary bladder: 51Cr-release assay. Int J Cancer. 1977;20:188. doi: 10.1002/ijc.2910200205. [DOI] [PubMed] [Google Scholar]
  • 30.Troye M, Perlmann P, Pape GR, Spiegelberg HL, Näslund I, Gidlöf A. The use of Fab-fragments of rabbit anti-human immunoglobulin as analytic tools for establishing the involvement of immunoglobulins in the spontaneous cytotoxicity of lymphocytes from patients with bladder carcinoma and from healthy donors. J Immunol. 1977;119:1061. [PubMed] [Google Scholar]
  • 31.Troye M, Pape GR, Larsson Å, Paulie S, Karlsson M, Perlmann P, Blomgren J, Johansson B. Disease-related in vitro cytotoxicity of lymphocytes from patients with transitional cell carcinoma of the urinary bladder. Comparisons with other malignancies, acute cystitis and healthy donors. Cancer Immunol Immunother. 1980;8:13. [Google Scholar]
  • 32.Troye M, Vilien M, Pape GR, Perlmann P. Cytotoxicity in vitro of blood lymphocytes from bladder cancer patients and controls to allogeneic or autologous tumor cells, derived from established cell lines or short-term cultures. Int J Cancer. 1980;25:33. doi: 10.1002/ijc.2910250105. [DOI] [PubMed] [Google Scholar]
  • 33.Troye M, Hansson Y, Paulie S, Perlmann P, Blomgren H, Johansson B. Lymphocyte-mediated lysis of tumor cells in vitro (ADCC), induced by serum antibodies from patients with urinary bladder carcinoma or from controls. Int J Cancer. 1980;25:45. doi: 10.1002/ijc.2910250106. [DOI] [PubMed] [Google Scholar]
  • 34.Union Internationale Contre le Cancer . TNM classification of malignant tumors. Geneva: UICC; 1974. [DOI] [PubMed] [Google Scholar]
  • 35.Wahren B, Perlmann P. Bladder and renal tumor markers. In: Sell S, Wahren B, editors. Human cancer markers. Clifton: Humana Press; 1982. p. 303. [Google Scholar]
  • 36.Walker L, Hay FC, Roitt IM. Characteristics of complexes for arming and inhibiting effector cells for antibody-dependent cell-mediated cytotoxicity. Clin Exp Immunol. 1979;36:397. [PMC free article] [PubMed] [Google Scholar]
  • 37.Vilien M, Wolf H, Rasmussen F. Titration of natural and disease-related cytotoxicity of lymphocytes from bladder cancer patients. Correlation with tumor classification. Cancer Immunol Immunother. 1980;8:189. [Google Scholar]
  • 38.Vilien M, Wolf H, Rasmussen F. Follow-up investigations of bladder cancer patients by titration of natural and specific lymphocyte-mediated cytotoxicity. Prognostic significance of specific reactivity. Cancer Immunol Immunother. 1981;10:171. [Google Scholar]
  • 39.Vilien M, Troye-Blomberg M, Perlmann P, Wolf H, Rasmussen F. Human spontaneous lymphocyte-mediated cytotoxicity (SLMC) against malignant and normal tissue-derived target cell lines tested in autologous and allogeneic combinations by the microcytotoxicity assay. Cancer Immunol Immunother. 1983;14:137. doi: 10.1007/BF00205351. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Vose BM. Specific T-cell-mediated killing of autologous lung tumor cells. Cell Immunol. 1980;55:12. doi: 10.1016/0008-8749(80)90132-x. [DOI] [PubMed] [Google Scholar]
  • 41.Vose BM, Vanky F, Klein E. Lymphocyte cytotoxicity against autologous tumor biopsy cells in humans. Int J Cancer. 1979;20:512. doi: 10.1002/ijc.2910200407. [DOI] [PubMed] [Google Scholar]
  • 42.Vose BM, Gallagher P, Moore M, Schoffield PF. Specific and non-specific lymphocyte cytotoxicity in colon carcinoma. Br J Cancer. 1981;44:846. doi: 10.1038/bjc.1981.283. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Cancer Immunology, Immunotherapy : CII are provided here courtesy of Springer

RESOURCES